These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 31895914)

  • 1. The safety and efficacy of tenofovir disoproxil fumarate used throughout pregnancy for mothers with chronic hepatitis B.
    Gao X; Duan X; Cai H; Hu Y; Liu M; Kang K; Zhou M; Fu D; Yi W
    Eur J Gastroenterol Hepatol; 2020 Dec; 32(12):1533-1537. PubMed ID: 31895914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of tenofovir disoproxil fumarate or telbivudine used throughout pregnancy for the prevention of mother-to-child transmission of hepatitis B virus: A cohort study.
    Li Z; Xie B; Yi N; Cai H; Yi W; Gao X
    Eur J Obstet Gynecol Reprod Biol; 2022 Sep; 276():102-106. PubMed ID: 35853269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tenofovir to Prevent Hepatitis B Transmission in Mothers with High Viral Load.
    Pan CQ; Duan Z; Dai E; Zhang S; Han G; Wang Y; Zhang H; Zou H; Zhu B; Zhao W; Jiang H;
    N Engl J Med; 2016 Jun; 374(24):2324-34. PubMed ID: 27305192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of telbivudine and tenofovir disoproxil fumarate in preventing hepatitis B vertical transmission: A real-life practice.
    Liu J; Wang J; Yan T; Du D; Qi C; Cao F; Yao N; Yang Y; He Y; Tian Z; Ren D; Zhu L; Chen T; Zhao Y
    J Viral Hepat; 2019 Oct; 26(10):1170-1177. PubMed ID: 31177596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of tenofovir disoproxil fumarate in pregnancy for the prevention of vertical transmission of HBV infection.
    Celen MK; Mert D; Ay M; Dal T; Kaya S; Yildirim N; Gulsun S; Barcin T; Kalkanli S; Dal MS; Ayaz C
    World J Gastroenterol; 2013 Dec; 19(48):9377-82. PubMed ID: 24409065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of maternal tenofovir disoproxil fumarate in interrupting mother-to-infant transmission of hepatitis B virus.
    Chen HL; Lee CN; Chang CH; Ni YH; Shyu MK; Chen SM; Hu JJ; Lin HH; Zhao LL; Mu SC; Lai MW; Lee CL; Lin HM; Tsai MS; Hsu JJ; Chen DS; Chan KA; Chang MH; ;
    Hepatology; 2015 Aug; 62(2):375-86. PubMed ID: 25851052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is the use of Tenofovir Dipivoxil fumarate effective and safe in preventing vertical transmission in pregnant women with chronic HBV with high viral load?
    Aladag H; Aladag M
    Eur Rev Med Pharmacol Sci; 2023 Mar; 27(5):2091-2098. PubMed ID: 36930508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of mother-to-child transmission of hepatitis B virus: a phase III, placebo-controlled, double-blind, randomized clinical trial to assess the efficacy and safety of a short course of tenofovir disoproxil fumarate in women with hepatitis B virus e-antigen.
    Jourdain G; Ngo-Giang-Huong N; Cressey TR; Hua L; Harrison L; Tierney C; Salvadori N; Decker L; Traisathit P; Sirirungsi W; Khamduang W; Bowonwatanuwong C; Puthanakit T; Siberry GK; Watts DH; Murphy TV; Achalapong J; Hongsiriwon S; Klinbuayaem V; Thongsawat S; Chung RT; Pol S; Chotivanich N
    BMC Infect Dis; 2016 Aug; 16():393. PubMed ID: 27506549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tenofovir Alafenamide to Prevent Perinatal Hepatitis B Transmission: A Multicenter, Prospective, Observational Study.
    Zeng QL; Yu ZJ; Ji F; Li GM; Zhang GF; Xu JH; Chen ZM; Cui GL; Li W; Zhang DW; Li J; Lv J; Li ZQ; Liang HX; Sun CY; Pan YJ; Liu YM; Wang FS
    Clin Infect Dis; 2021 Nov; 73(9):e3324-e3332. PubMed ID: 33395488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term growth and bone development in children of HBV-infected mothers with and without fetal exposure to tenofovir disoproxil fumarate.
    Wen WH; Chen HL; Shih TT; Wu JF; Ni YH; Lee CN; Zhao LL; Lai MW; Mu SC; Tung YC; Hsu HY; Chang MH;
    J Hepatol; 2020 Jun; 72(6):1082-1087. PubMed ID: 32044401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Real-world study of tenofovir disoproxil fumarate to prevent hepatitis B transmission in mothers with high viral load.
    Wang M; Bian Q; Zhu Y; Pang Q; Chang L; Li R; Tiongson BC; Zhang H; Pan CQ
    Aliment Pharmacol Ther; 2019 Jan; 49(2):211-217. PubMed ID: 30506691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tenofovir rescue therapy in pregnant females with chronic hepatitis B.
    Hu YH; Liu M; Yi W; Cao YJ; Cai HD
    World J Gastroenterol; 2015 Feb; 21(8):2504-9. PubMed ID: 25741161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the efficacy and safety of TAF, TDF, and LdT to prevent the transmission of hepatitis B in pregnant women: A retrospective study.
    Pan S; Zhang Y; Zeng Y; Lin C
    Immun Inflamm Dis; 2024 Feb; 12(2):e1204. PubMed ID: 38414328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tenofovir versus Placebo to Prevent Perinatal Transmission of Hepatitis B.
    Jourdain G; Ngo-Giang-Huong N; Harrison L; Decker L; Khamduang W; Tierney C; Salvadori N; Cressey TR; Sirirungsi W; Achalapong J; Yuthavisuthi P; Kanjanavikai P; Na Ayudhaya OP; Siriwachirachai T; Prommas S; Sabsanong P; Limtrakul A; Varadisai S; Putiyanun C; Suriyachai P; Liampongsabuddhi P; Sangsawang S; Matanasarawut W; Buranabanjasatean S; Puernngooluerm P; Bowonwatanuwong C; Puthanakit T; Klinbuayaem V; Thongsawat S; Thanprasertsuk S; Siberry GK; Watts DH; Chakhtoura N; Murphy TV; Nelson NP; Chung RT; Pol S; Chotivanich N
    N Engl J Med; 2018 Mar; 378(10):911-923. PubMed ID: 29514030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tenofovir alafenamide or tenofovir disoproxil fumarate in pregnancy to prevent HBV transmission: Maternal ALT trajectory and infant outcomes.
    Chen HL; Lee CN; Chang CH; Lai MW; Tsai MC; Mu SC; Liu CJ; Shih JC; Wen WH; Hu RT; Huang CP; Hu KC; Chen CP; Lee CL; Chien RN; Chang KC; Hsu HY; Lee CC; Ni YH; Chang MH
    Liver Int; 2024 Jun; 44(6):1422-1434. PubMed ID: 38456620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of tenofovir disoproxil fumarate and telbivudine in preventing hepatitis B transmission in mothers with high viral load.
    Wang M; Ran R; Zhu Y; Zhang H
    Int J Gynaecol Obstet; 2023 Feb; 160(2):646-652. PubMed ID: 35816243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the efficacy and safety of tenofovir and telbivudine in interrupting mother-to-child transmission of hepatitis B virus.
    Zhu B; Lv X; Zhao Z; Chen L; Chen X; Li C; Li S; Dai E
    Medicine (Baltimore); 2021 Nov; 100(44):e27695. PubMed ID: 34871254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of antiviral prophylaxis during pregnancy to prevent mother-to-child transmission of hepatitis B virus: a systematic review and meta-analysis.
    Funk AL; Lu Y; Yoshida K; Zhao T; Boucheron P; van Holten J; Chou R; Bulterys M; Shimakawa Y
    Lancet Infect Dis; 2021 Jan; 21(1):70-84. PubMed ID: 32805200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pregnancy Outcome of Women with Chronic Hepatitis B who Discontinued Antiviral Treatment before or in the Early Pregnancy.
    Gao X; Duan X; Cai H; Hu Y; Liu M; Kang K; Zhou M; Fu D; Yi W
    Int J Med Sci; 2020; 17(2):170-175. PubMed ID: 32038100
    [No Abstract]   [Full Text] [Related]  

  • 20. Safety and efficacy of lamivudine or telbivudine started in early pregnancy for mothers with active chronic hepatitis B.
    He T; Bai Y; Cai H; Ou X; Liu M; Yi W; Jia J
    Hepatol Int; 2018 Mar; 12(2):118-125. PubMed ID: 29344772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.